<DOC>
	<DOCNO>NCT02660437</DOCNO>
	<brief_summary>Investigators wish identify relationship substantial change carbon dioxide partial-pressure ( pCO2 ) , frequently occur transition rest exercise ( ΔpCO2 &gt; 4 millimeter mercury [ mmHg ] baseline ) , prevalence cognitive dysfunction COPD . In particular , anticipated investigate vascular effect pCO2 oscillation regulation cerebral blood flow ( CBF ) exercise impact cognitive function Chronic Obstructive Pulmonary Disease ( COPD ) . Furthermore , study aim examine whether major pCO2 oscillation prognostic value cognitive deterioration 6 , 12 , 18-month follow-up . In addition , acute effect 3-week pulmonary rehabilitation ( PR ) cognitive function explore . The evaluation cognitive function perform use Standardized Mini Mental State Examination ( SMMSE ) , Addenbrooke 's Cognitive Examination ( ACE-R ) , Montreal Cognitive Assessment ( MoCA ) , Telephone Interview Cognitive Status ( TICS ) assess several cognitive domain ( cognitive score ) whereas Stroop test [ color read interference ] use measure cognitive performance ( Reaction-Time ) .</brief_summary>
	<brief_title>pCO2 Oscillations During Exercise : Relation Cerebral Blood Flow Cognitive Dysfunction COPD</brief_title>
	<detailed_description>Cerebral Blood Flow ( CBF ) regulation crucial adequate oxygen supply brain sustenance cerebrovascular reserve capacity . A fundamental physiologic regulator CBF carbon dioxide partial pressure ( pCO2 ) , determine dilatation contraction cerebral vasculature . CBF regulation response find strongly dependent upon pCO2 much less upon change arterial oxygen saturation . CBF highly sensitive pCO2 change cause pronounced-vasodilatation increase pCO2 ( CBF augmentation ) vasoconstriction decrease pCO2 level ( CBF diminution ) . During cerebral activation increase metabolism , cerebral arteriole dilate contribute increase CBF process often challenge exercise potential impact cognitive function . CBF link cognitive function serum level Brain Derived Neurotrophic Factor ( BDNF ) show critical driving force behind neural plasticity potential utility biomarker cognitive decline . Investigators assume major pCO2 oscillation exercise ( ΔpCO2 &gt; 4 millimeter mercury [ mmHg ] baseline ) reflection abnormality ventilatory efficiency/drive , lead overall local disturbance cerebral blood flow ( CBF ) thus associate increased prevalence cognitive dysfunction patient Chronic Obstructive Pulmonary Disease ( COPD ) . Moreover , investigator hypothesize patient major pCO2 oscillation exercise may develop bad cognitive impairment several cognitive domain great cognitive decline compare `` isocapnic '' patient 6 , 12 , 18-month follow-up . Inpatient PR may benefit cognitive function improve breathing ( diminish pCO2 oscillation ) , therefore improve CBF , increase cerebral neural activation exercise . With regard cognitive dysfunction , associate increase all-cause mortality disability , investigator wish : ( A ) detect relationship major pCO2 oscillation exercise increase prevalence cognitive dysfunction COPD ; ( B ) investigate impact different pCO2 transitory-patterns ( 1. pCO2 : decline/ hypocapnic , 2. steady/ isocapnic , 3. increase/ hypercapnic ) CBF regulation cognitive function ; ( C ) examine whether major pCO2 oscillation determinant great cognitive deterioration several cognitive domain 6 , 12 , and18-month follow-up ( D ) explore acute effect 3-week PR pCO2 oscillation CBF respect cognitive function COPD patient cognitive impairment . The evaluation cognitive function perform use Standardized Mini Mental State Examination ( SMMSE ) , Addenbrooke 's Cognitive Examination ( ACE-R ) , Montreal Cognitive Assessment ( MoCA ) Telephone Interview Cognitive Status ( TICS ) assess several cognitive domain ( cognitive score ) whereas Stroop test use measure cognitive performance ( Reaction-Time ) .</detailed_description>
	<mesh_term>Lung Diseases</mesh_term>
	<mesh_term>Lung Diseases , Obstructive</mesh_term>
	<mesh_term>Pulmonary Disease , Chronic Obstructive</mesh_term>
	<mesh_term>Cognition Disorders</mesh_term>
	<criteria>Patients Chronic Obstructive Pulmonary Disease ( COPD ) Global Initiative Obstructive Lung Disease ( GOLD ) stag II IV COPD patient mild moderate cognitive impairment ( MCIgroup : n=100 ) without cognitive impairment ( Controlgroup : n=60 ) Normotensive ( Blood Pressure range : 101143/6291 millimeter mercury [ mmHg ] ) Resting partial pressure oxygen arterial blood ( paO2 ) &lt; 55 millimeter mercury [ mmHg ] Resting partial pressure carbon dioxide arterial blood ( paCO2 ) &gt; 45 millimeter mercury [ mmHg ] last exacerbation ≤4weeks severe cognitive impairment/dementia neuropsychiatric symptom</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>COPD</keyword>
	<keyword>Carbon dioxide partial pressure ( pCO2 )</keyword>
	<keyword>Cerebral blood flow ( CBF )</keyword>
	<keyword>Cognitive dysfunction</keyword>
	<keyword>Mild/Moderate Cognitive Impairment ( MCI )</keyword>
	<keyword>Pulmonary Rehabilitation ( PR )</keyword>
	<keyword>Standardized Mini Mental State Examination ( SMMSE )</keyword>
	<keyword>Addenbrooke 's Cognitive Examination ( ACE-R )</keyword>
	<keyword>Montreal Cognitive Assessment ( MoCA )</keyword>
	<keyword>Telephone Interview Cognitive Status ( TICS )</keyword>
	<keyword>Stroop test ( Reaction Time )</keyword>
</DOC>